Papillary thyroid cancer in a patient with interstitial 6q25 deletion including ARID1B

American Journal of Medical Genetics, Part A

Volumn 164, Issue 7, 2014, Pages 1857-1859

  Vengoechea, Jaime ^a   Carpenter, Lori ^a   Zárate, Yuri A ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; HEPARAN N SULFATASE; LEVOTHYROXINE; PROTEIN; UNCLASSIFIED DRUG; ARID1B PROTEIN, HUMAN; DNA BINDING PROTEIN; TRANSCRIPTION FACTOR;

6Q25 DELETION; ADULT; ARID1B GENE; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CHROMOSOME DELETION; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; ENZYME ASSAY; FACE DYSMORPHIA; FOCAL EPILEPSY; GENE; GERMLINE MUTATION; HEAD CIRCUMFERENCE; HEARING IMPAIRMENT; HUMAN; INTELLIGENCE QUOTIENT; MALE; MYOPIA; PRIORITY JOURNAL; SINUS TACHYCARDIA; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TONIC CLONIC SEIZURE; CARCINOMA; CHROMOSOME 6; FACIES; GENETICS; PHENOTYPE; THYROID NEOPLASMS;

ADULT; CARCINOMA; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 6; DNA-BINDING PROTEINS; FACIES; HUMANS; MALE; PHENOTYPE; THYROID NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 84902537287     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.36515     Document Type: Article

References (16)

1. Dalsass A, Mestichelli F, Ruggieri M, Gaspari P, Pezzoni V, Vagnoni D, Angelini M, Angelini S, Bigazzi C, Falcioni S, Troiani E, Alesiani F, Catarini M, Attolico I, Scortechini I, Discepoli G, Galieni P. 2013. 6q deletion detected by fluorescence in situ hybridization using bacterial artificial chromosome in chronic lymphocytic leukemia. Eur J Haematol 91:10-19.
2. Fujimoto A, Totoki Y, Abe T, Boroevich KA, Hosoda F, Nguyen HH, Aoki M, Hosono N, Kubo M, Miya F, Arai Y, Takahashi H, Shirakihara T, Nagasaki M, Shibuya T, Nakano K, Watanabe-Makino K, Tanaka H, Nakamura H, Kusuda J, Ojima H, Shimada K, Okusaka T, Ueno M, Shigekawa Y, Kawakami Y, Arihiro K, Ohdan H, Gotoh K, Ishikawa O, Ariizumi S, Yamamoto M, Yamada T, Chayama K, Kosuge T, Yamaue H, Kamatani N, Miyano S, Nakagama H, Nakamura Y, Tsunoda T, Shibata T, Nakagawa H. 2012. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet 44:760-764.
3. Hunter Shain A, Pollack JR. 2013. The spectrum of SWI/SNF mutations, ubiquitous in human cancers. PLoS ONE 8:e55119.
4. Khursheed M, Kolla JN, Kotapalli V, Gupta N, Gowrishankar S, Uppin SG, Sastry RA, Koganti S, Sundaram C, Pollack JR, Bashyam MD. 2013. ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell ines. Br J Cancer 108:2056-2062.
5. Michelson M, Ben-Sasson A, Vinkler C, Leshinsky-Silver E, Netzer I, Frumkin A, Kivity S, Lerman-Sagie T, Lev D. 2012. Delineation of the interstitial 6q25 microdeletion syndrome: Refinement of the critical causative region. Am J Med Genet A 158A:1395-1399.
6. Monoranu CM, Huang B, Zangen IL, Rutkowski S, Vince GH, Gerber NU, Puppe B, Roggendorf W. 2008. Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas. Cancer Genet Cytogenet 182:18-26.
7. Nagamani SC, Erez A, Eng C, Ou Z, Chinault C, Workman L, Coldwell J, Stankiewicz P, Patel A, Lupski JR, Cheung SW. 2009. Interstitial deletion of 6q25.2-q25.3: A novel microdeletion syndrome associated with microcephaly, developmental delay, dysmorphic features and hearing loss. Eur J Hum Genet 17:573-581.
8. Romei C, Elisei R. 2012. RET/PTC translocations and clinico-pathological features in human papillary thyroid carcinoma. Front Endocrinol (Lausanne) 3:54.
9. Santen GW, Aten E, Sun Y, Almomani R, Gilissen C, Nielsen M, Kant SG, Snoeck IN, Peeters EA, Hilhorst-Hofstee Y, Wessels MW, den Hollander NS, Ruivenkamp CA, van Ommen GJ, Breuning MH, den Dunnen JT, van Haeringen A, Kriek M. 2012. Mutations in SWI/SNF chromatin remodeling complex gene ARID1B cause Coffin-Siris syndrome. Nat Genet 44:379-380.
10. Santen GW, Aten E, Vulto-van Silfhout AT, Pottinger C, van Bon BW, van Minderhout IJ, Snowdowne R, van der Lans CA, Boogaard M, Linssen MM, Vijfhuizen L, van der Wielen MJ, Vollebregt MJ, Coffin-Siris Consortium Breuning MH, Kriek M, van Haeringen A, den Dunnen JT, Hoischen A, Clayton-Smith J, de Vries BB, Hennekam RC, van Belzen MJ. 2013. Coffin-Siris syndrome and the BAF complex: Genotype-phenotype study in 63 patients. Hum Mutat 11:1519-1528.
11. Sausen M, Leary RJ, Jones S, Wu J, Reynolds CP, Liu X, Blackford A, Parmigiani G, Diaz LA, Jr. Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE, Hogarty MD. 2013. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Nat Genet 45:12-17.
12. Schrier Vergano S, Santen G, Wieczorek D, Wollnik B, Matsumoto N, Deardorff MA. 2013. Coffin-Siris syndrome. In: Pagon RA, Adam MP, Bird TD, et al., editors. GeneReviews. Seattle (WA): University of Washington, Seattle.
13. Tsurusaki Y, Okamoto N, Ohashi H, Kosho T, Imai Y, Hibi-Ko Y, Kaname T, Naritomi K, Kawame H, Wakui K, Fukushima Y, Homma T. et al. 2012. Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. Nat Genet 44:376-378.
14. Tsurusaki Y, Okamoto N, Ohashi H, Mizuno S, Matsumoto N, Makita Y, Fukuda M, Isidor B, Perrier J, Aggarwal S, Dalal A, Al-Kindy A, Liebelt J, Mowat D, Nakashima M, Saitsu H, Miyake N, Matsumoto N. 2013. Coffin-Siris syndrome is a SWI/SNF complex disorder. Clin Genet doi: 10.1111/cge.12225.
15. Yu L, Reader JC, Chen C, Zhao XF, Ha JS, Lee C, York T, Gojo I, Baer MR, Ning Y. 2011. Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acute myeloid leukemia. Leukemia 25:367-371.
16. Weetman AP. 2012. Chapter 341 disorders of the thyroid gland. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison's principles of internal medicine, 18th edition. New York: McGraw-Hill.